近年来，随着表皮生长因子受体-酪氨酸激酶抑制剂（EGFR-TKI）在非小细胞肺癌（NSCLC）中的广泛应用，耐药问题逐渐成为临床痛点。 2025 年美国临床肿瘤学会（ASCO）年会中，SACHI 研究公布更新数据，在 EGFR-TKIs ...

Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...

FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...

The FDA has blessed AstraZeneca and Daiichi Sankyo’s Datroway to treat patients with locally advanced or metastatic epidermal ...

DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) who have ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

FirstHealth of the Carolinas will offer free lung cancer screenings using its mobile Lung Bus at FirstHealth Lee Campus located at 2919 Beechtree Drive in Sanford from 8:30 a.m. to 12:30 p.m. on ...

Australians with a high risk of developing lung cancer can be screened for the disease free of charge through Medicare.This is ...

Patients with brain metastases from gastrointestinal cancers show worse survival after stereotactic radiosurgery than those ...